Ownership history in BB BIOTECH AG · 17 quarters on record
This page tracks every 13F SEC filing in which BB BIOTECH AG reported a position in Intercept Pharmaceuticals (ICPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2019 Q1 | ADDED | 696,976 | +121,257 | +21.1% | 1.96% | $78.0M | — |
| 2018 Q4 | ADDED | 575,719 | +30,000 | +5.5% | 1.86% | $58.0M | — |
| 2018 Q3 | UNCHANGED | 545,719 | — | 0% | 1.82% | $69.0M | — |
| 2018 Q2 | UNCHANGED | 545,719 | — | 0% | 1.32% | $45.8M | — |
| 2018 Q1 | ADDED | 545,719 | +60,000 | +12.4% | 0.93% | $33.6M | — |
| 2017 Q4 | UNCHANGED | 485,719 | — | 0% | 0.80% | $28.4M | — |
| 2017 Q3 | ADDED | 485,719 | +230,000 | +89.9% | 0.78% | $28.2M | — |
| 2017 Q2 | UNCHANGED | 255,719 | — | 0% | 0.95% | $31.0M | — |
| 2017 Q1 | UNCHANGED | 255,719 | — | 0% | 0.95% | $28.9M | — |
| 2016 Q4 | UNCHANGED | 255,719 | — | 0% | 1.03% | $27.8M | — |
As of 2023 Q3 — sorted by position size